Baldwin Wealth Partners’s Cambria Cannabis ETF TOKE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,400
Closed -$9K 828
2022
Q3
$9K Hold
1,400
﹤0.01% 527
2022
Q2
$11K Hold
1,400
﹤0.01% 528
2022
Q1
$16K Hold
1,400
﹤0.01% 500
2021
Q4
$17K Hold
1,400
﹤0.01% 463
2021
Q3
$20K Hold
1,400
﹤0.01% 455
2021
Q2
$25K Hold
1,400
﹤0.01% 448
2021
Q1
$29K Buy
+1,400
New +$28.2K ﹤0.01% 416

Other funds holding TOKE

Baldwin Wealth Partners's TOKE Position: Q4 2022 in Review

Baldwin Wealth Partners sold out of Cambria Cannabis ETF (TOKE) in Q4 2022, closing a stake of 1,400 shares — an estimated $9K sold.

Baldwin Wealth Partners first reported a position in TOKE in Q1 2021 and held it in 7 quarters. The position peaked at $29K in Q1 2021. 23 funds tracked by Wall St. Rank hold TOKE as of Q4 2022.

  • Baldwin Wealth Partners reported no remaining Cambria Cannabis ETF position as of Q4 2022 after selling out during the quarter.
  • Baldwin Wealth Partners sold 1,400 Cambria Cannabis ETF shares in Q4 2022, an estimated $9K.
  • Baldwin Wealth Partners first reported a position in Cambria Cannabis ETF in Q1 2021 and held it in 7 quarters.
  • Baldwin Wealth Partners's Cambria Cannabis ETF position peaked at $29K in Q1 2021.
  • 23 funds tracked by Wall St. Rank held Cambria Cannabis ETF as of Q4 2022.

Based on Baldwin Wealth Partners's 13F filing for Q4 2022, filed 27 Jan 2023.